...its cell-based protein interaction screening platform. Under the four-year collaboration, Novartis AG (NYSE:NVS; SIX:NOVN) and Orionis Biosciences...
...markers on cell types, avoiding systemic toxicities associated with the modality. Elizabeth S. Eaton, Staff Writer Novartis AG Orionis Biosciences protein...

...hired Robert Brenner as EVP and head of R&D. He was EVP and CMO of Orionis Biosciences LLC...

...Belgium) and Orionis Biosciences LLC (Boston, Mass.). Takke declined to disclose details regarding Orionis' pipeline. Virginia Li Confo Therapeutics N.V. Orionis Biosciences LLC Oxular...

...in screening assays (see BioCentury, July 27, 2015) . V-Bio also invested in VIB spinout Orionis Biosciences LLC...